CEO Lungpacer Medical: We are developing a novel therapeutic solution for preserving the integrity and strength of the diaphragm muscle, protecting and improving lung and cognitive function, and increasing cardiac output in critically ill patients who require mechanical ventilation. The proprietary Lungpacer system activates the diaphragm using a temporary, minimally invasive, nerve stimulation approach that will save many lives, improve surviving patient outcomes and greatly reduce hospital care costs.
Board Chair TELABio (NASDAQ:TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of natural tissue reinforcement materials that are purposefully designed to address unmet needs in soft tissue reconstruction.
Board Member WhiteSwell Medical, a private company dedicated to improving treatment of acute decompensated heart failure (ADHF), a primary cause of repeat hospitalization and emergency room visits.
Former Board Member Intact Vascular: Founded in 2011, Intact Vascular developed minimally invasive peripheral vascular products designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease. Acquired by Philips Medical for $360M in 2020.
Former Chief Operating Officer of Kensey Nash Corporation (NASDAQ:KNSY) based in Exton PA, which was acquired for $360M by Royal DSM. Accomplished business leader, strategist, and inventor in the medical device and regenerative medicine field. Results driven leader with experience in growing revenue and EBITDA performance by balancing organic growth initiatives and acquisitions. Serial innovator with 100 issued US patents that cover products which have been used in over 15 million patients world-wide and generated greater than $4 billion in end-user sales.
CEO Lungpacer Medical: We are developing a novel therapeutic solution for preserving the integrity and strength of the diaphragm muscle, protecting and improving lung and cognitive function, and increasing cardiac output in critically ill patients who require mechanical ventilation. The proprietary Lungpacer system activates the diaphragm using a temporary, minimally invasive, nerve stimulation approach that will save many lives, improve surviving patient outcomes and greatly reduce hospital care costs.
Board Chair TELABio (NASDAQ:TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of natural tissue reinforcement materials that are purposefully designed to address unmet needs in soft tissue reconstruction.
Board Member WhiteSwell Medical, a private company dedicated to improving treatment of acute decompensated heart failure (ADHF), a primary cause of repeat hospitalization and emergency room visits.
Former Board Member Intact Vascular: Founded in 2011, Intact Vascular developed minimally invasive peripheral vascular products designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease. Acquired by Philips Medical for $360M in 2020.
Former Chief Operating Officer of Kensey Nash Corporation (NASDAQ:KNSY) based in Exton PA, which was acquired for $360M by Royal DSM. Accomplished business leader, strategist, and inventor in the medical device and regenerative medicine field. Results driven leader with experience in growing revenue and EBITDA performance by balancing organic growth initiatives and acquisitions. Serial innovator with 100 issued US patents that cover products which have been used in over 15 million patients world-wide and generated greater than $4 billion in end-user sales.
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy